VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma — David S. Siegel (2016) | RDL Network
VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
David S. Siegel, Sundar Jagannath, Sagar Lonial, Meletios A Dimopoulos, Thorsten Graef, Dina Pietrangelo, Lisa Lupinacci, David Reiser, Syed Rizvi, Kenneth C. Anderson
David S. Siegel, Sundar Jagannath, Roman Hájek, Meletios A Dimopoulos, Sung‐Soo Yoon, Sagar Lonial, Jacob P. Laubach, Thorsten Graef, Dina Pietrangelo, Lisa Lupinacci, David Reiser, Kenneth C. Anderson
David S. Siegel, Meletios A Dimopoulos, Sung‐Soo Yoon, Jacob P. Laubach, Jonathan L. Kaufman, Hartmut Goldschmidt, Donna Reece, Xavier Leleu, Simon Durrant, Fritz Offner, Michèle Cavo, Arnon Nagler, Sundar Jagannath, Thorsten Graef, Jennifer Houp, Linda Sun, J. Howe, Sandra Wear, Kenneth C. Anderson
Meletios A Dimopoulos, Sundar Jagannath, Sung‐Soo Yoon, David S. Siegel, Sagar Lonial, Roman Hájek, Thierry Façon, Laura Rosiñol, Hilary Blacklock, Hartmut Goldschmidt, Vânia Hungria, Andrew Spencer, Antonio Palumbo, Donna Reece, Thorsten Graef, Jennifer Houp, Linda Sun, Joseph Eid, Kenneth C. Anderson
Meletios A Dimopoulos, David S. Siegel, Sagar Lonial, Junyuan Qi, Roman Hájek, Thierry Façon, Laura Rosiñol, Catherine Williams, Hilary Blacklock, Hartmut Goldschmidt, Vânia Hungria, Andrew Spencer, Antonio Palumbo, Thorsten Graef, Joseph Eid, Jennifer Houp, Linda Sun, Scott Vuocolo, Kenneth C. Anderson
Discussion(0)
No comments yet. Be the first to comment.